Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 24.8716.1331.1828.05-1.30

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 24.87 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05
Mar2020-1.30

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05
Positive
Mar2020 -1.3 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,973.2 Cr 5.9% 17.1% -2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.9%

17.1%

-2.2%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses